Female research

We only offer products with clinically documented effects. It becomes so much better that way.

 

Vagvital has undergone clinical tests in a multicenter study where effects as well as safety were documented, together with 90 patients.   

Behind the study are dedicated female researchers from Karolinska University Hospital, Uppsala University Hospital, and Norrland University Hospital. And they are all passionate about promoting women's health.

The clinical study showed several positive effects. As many as 79% of the patients experienced an improvement in their most troublesome symptoms. Something that has made VagiVital therefore classified as an active gel, as the gel's clinically proven effects do more than just moisturize. The following improvements were documented:

  • Reduced symptoms of dry mucous membranes (itching, irritation, pain during intercourse, and pain during urination).
  • Reduced symptoms of urge incontinence.
  • Improvement of vaginal pH and the number of cells in the surface layer of the vaginal mucosa.
     

The effects of VagiVital on the most troublesome symptoms are at the same level as estrogen preparations, with the big difference that VagiVital is completely hormone-free.

DOWNLOAD THE STUDY

 

 

Customer Survey

VagiVital has conducted a customer survey to evaluate how VagiVital has been received by and worked for users since the product became available on the Swedish market in July 2018.

210 women who used VagiVital for at least one month were asked in a digital customer survey to answer a number of questions about their experiences with VagiVital as a product. Among other things, participants were asked about the degree of improvement and how they experienced the included applicator and instructions.

The survey shows that since its launch on the Swedish market, VagiVital has proven to be both safe and effective, with a clear perceived improvement of symptoms in 81% of users.

One can also see a clear trend that the improvement in results increases the longer one has used VagiVital. Of those who used VagiVital for 2 months or longer, as many as 89% experienced a clear symptom improvement. The results are in line with VagiVital's previous clinical studies.

Proportion of women with perceived improvement of symptoms after using VagiVital for:

  • One month - 77%
  • More than 2 months - 89%
     

*Since VagiVital is so new on the market, only a few people have used the product for longer than 3 months.

85% of women would recommend VagiVital to someone they know.

CUSTOMER SURVEY

 

 

 
Research for change! 

Did you know that research on genital parts has increased since the 2000s? That is promising. But worrying is that only 10% of that increase has been on women alone. Female genital health has long been underprioritized. But we are working for change!

We work for more equal research, where focus on women's health should also be prioritized. Do you agree? Support female genital research and sign our petition here.

VagiVital works to create more funds for female genital research. The appeal is supported by Associate Professor Aino Fianu Jonasson, Karolinska Institutet, and Professor Inger Sundström Poromaa, Akademiska sjukhuset, and we collaborate with the 1.6 Million Club. From VagiVital's sales, 1% of the revenue goes to the 1.6 Million Club's important work for women's health, through their 90-account 123-900 15 20. Together we will raise the issue, highlight the area, and equalize the differences. Support us in the fight for increased focus on female genital research!